This brand name is authorized in Nigeria
The drug COLLOMAK contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Salicylic acid
UNII O414PZ4LPZ - SALICYLIC ACID
|
|
Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. |
|
2
Lactic acid
UNII 33X04XA5AT - LACTIC ACID, UNSPECIFIED FORM
|
|
|
|
3
Polidocanol
UNII 0AWH8BFG9A - POLIDOCANOL
|
|
Polidocanol has a concentration-dependent and volume-dependent damaging effect on the endothelium of blood vessels. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D11AF | Wart and anti-corn preparations | D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: NG | Registered Drug Product Database | Identifier(s): B4-6140 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
